Vivek Ramaswamy
About Vivek Ramaswamy
Vivek Ramaswamy is the Chief Executive Officer of Roivant Sciences and has held various leadership roles in the biotechnology sector, including positions at Axovant Sciences and Arbutus Biopharma Corporation. He is a Harvard University graduate and a former Republican Party presidential candidate.
Work at Roivant Sciences
Vivek Ramaswamy has served as the Chief Executive Officer of Roivant Sciences since its founding in 2014. Under his leadership, the company has focused on advancing innovative therapies and improving patient outcomes. Roivant Sciences operates with a unique business model that emphasizes the development of medicines through a network of subsidiary companies. Ramaswamy's role involves strategic oversight and direction, guiding the company's vision and operational execution in the biopharmaceutical sector.
Previous Roles and Experience
Before his tenure at Roivant Sciences, Vivek Ramaswamy held several significant positions in the biotechnology and finance sectors. He was the Chief Executive Officer of Axovant Sciences from 2014 to 2017 and served as a Board Member from 2014 to 2018. Additionally, he was the Chairman of the Board of Directors at Arbutus Biopharma Corporation from 2014 to 2018. Ramaswamy also worked as a Partner at Qvt Financial Lp from 2007 to 2014, where he gained extensive experience in investment management.
Education and Expertise
Vivek Ramaswamy earned a Bachelor of Arts in Biology from Harvard University, where he studied from 2003 to 2007. He furthered his education at Yale Law School, obtaining a Doctor of Jurisprudence. His academic background in biology and law equips him with a unique perspective in the biopharmaceutical industry, combining scientific knowledge with legal and regulatory expertise.
Involvement in Myovant Sciences
Ramaswamy has been a Board Member at Myovant Sciences since 2016. His involvement in the company reflects his commitment to advancing healthcare solutions, particularly in the areas of reproductive health and prostate cancer. His role on the board contributes to the strategic guidance and oversight of Myovant Sciences as it develops innovative therapies.
Political Involvement
Vivek Ramaswamy is a former Republican Party presidential candidate. His candidacy reflects his engagement in political discourse and public policy, particularly concerning healthcare and biotechnology. This involvement highlights his interest in influencing the regulatory and economic landscape of the biopharmaceutical industry.